As the White House anticipates approval of the Emergency Use Authorization (EUA) application for COVID vaccines for babies and young children, Dr. Jay Bhattacharya, professor of health policy at Stanford University, and a founding fellow at the Academy for Science and Freedom, says the claim that COVID is “a far greater threat to kids than the flu is” amounts to “scare-mongering.”
Bhattacharya responded in a column at the Wall Street Journal Sunday to White House COVID-19 Response Coordinator Dr. Ashish Jha’s recent tweet in which he made the claim “COVID is a far greater threat to kids than the flu is.”
Pfizer announced last week the Food and Drug Administration (FDA) had asked the drug company, and its partner BioNTech, to submit data on a COVID vaccine series for babies as young as 6 months old.
Albert Bourla, chairman and CEO of Pfizer, said in the statement:
As hospitalizations of children under 5 due to COVID-19 have soared, our mutual goal with the FDA is to prepare for future variant surges and provide parents with an option to help protect their children from this virus. Ultimately, we believe that three doses of the vaccine will be needed for children 6 months through 4 years of age to achieve high levels of protection against current and potential future variants. If two doses are authorized, parents will have the opportunity to begin a COVID-19 vaccination series for their children while awaiting potential authorization of a third dose.
A doctor and professor with Johns Hopkins University said in a recent television appearance that, contrary to the official government narrative, those who actually catch the coronavirus and recover are approximately seven times more immune from future infections than those who receive a vaccine, as reported by the Daily Caller.
Dr. Marty Makary, during his interview on the Vince Coglianese Show, said studies have proven that “natural immunity is better against the Delta variant” than vaccines. “When you get infected with COVID, your body’s immune system develops antibodies to the entire surface of the virus. Not just the slight protein that the vaccines give you, but the entire surface. And so, you get a more diverse antibody portfolio in your system.”